Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2025-12-25 @ 3:32 AM
NCT ID:
NCT02918305
Eligibility Criteria:
Inclusion Criteria:
* average office systolic BP of 150 mmHg or greater or office diastolic BP of 90 mmHg or greater (both in the sitting position)
* 24-hr ambulatory BP 140 mmHg or greater.
Exclusion Criteria:
* Secondary hypertension (sleep apnoea can be included.)
* Type I diabetes or uncontrolled Type II diabetes with HbA1c 8.4% or greater
* Known or concurrent chronic active inflammatory bowel diseases (e.g. Crohn's disease, ulcerative colitis etc.)
* eGFR\<40 mL/min/1.73m2 (per predictive equation Japanese Society of Nephrology)
* Known severe cardiovascular events within 3 months or severe cerebrovascular events
* Patients those who are planned to receive PCI or other operation for iscaemic cardiovascular disease within 8 months
* Concurrent persistent atrial fibrillation
* Patients those who are on active implantable medical devices
* Primary pulmonary hypertension
* Patients those who are contraindicated to, or confirmed to have intolerable anaphylactic reaction or uncontrollable allergy to contrast media
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT02918305
Study Brief:
Protocol Section:
NCT02918305